Dr. Reddy's Laboratories Ltd Common Stock vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B), while Direxion Daily Semiconductor Bear 3X Shares trades at $45.56 (market cap $2.51B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 4.2× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| RDY | SOXS | |
|---|---|---|
Market Cap | $10.61B | $2.51B |
Volume | 3,738,869 | 88,764,629 |
Sector | Health | Leveraged / Inverse |
52-Week High | $15.38 | $944.00 |
52-Week Low | $11.38 | $29.62 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $10.51B | — |
Dividend Yield | 0.65% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOXS (Direxion Daily Semiconductor Bear 3X ETF) trades at $37.42, up 0.48% with a bullish technical signal despite mixed moving averages. The ETF shows extreme volatility as a leveraged inverse product betting against semiconductor stocks. Recent news highlights semiconductor sector volatility and AI-driven demand pressures on bearish positions. Technical indicators show RSI at overbought levels while ADX signals strong trend direction.
As a leveraged inverse ETF, SOXS carries significant decay risk and is unsuitable for long-term holding. Current technical setup suggests short-term bearish semiconductor positioning faces headwinds from persistent AI demand. The product's structure makes it highly sensitive to daily semiconductor index movements, requiring careful risk management for tactical traders.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →